(Q40960279)

25 September 2017

1 reference

title

Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies (English)

1 reference

25 September 2017

1 reference

3

J B Severe

1 reference

25 September 2017

N R Schooler

1

1 reference

25 September 2017

S J Keith

series ordinal

2

1 reference

25 September 2017

S M Matthews

series ordinal

4

1 reference

25 September 2017

publication date

1 January 1995

1 reference

25 September 2017

published in

Psychiatric Quarterly

1 reference

25 September 2017

volume

66

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

279-292

1 reference

Overview: maintenance therapy in psychiatry: I. Schizophrenia

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02238750

Maintenance Medication for Schizophrenia: Strategies for Dose Reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238750

Psychopharmacologic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238750

Drug and Family Therapy in the Aftercare of Acute Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238750

Costs and benefits of two doses of fluphenazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238750

Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238750

Psychosocial treatment for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238750

Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238750

Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238750

Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02238750

Influence of Family Life on the Course of Schizophrenic Disorders: A Replication

21 January 2018

1 reference

12 December 2020

A trial of family therapy v. a relatives group for schizophrenia

1 reference

12 December 2020

A controlled trial of social intervention in the families of schizophrenic patients: two year follow-up

1 reference

12 December 2020

High-dose versus low-dose strategies in the treatment of schizophrenia

1 reference

12 December 2020

Behavioural family management in schizophrenia. Outcome of a clinic-based intervention.

1 reference

12 December 2020

A controlled trial of social intervention in the families of schizophrenic patients.

1 reference

12 December 2020

The community management of schizophrenia. A controlled trial of a behavioural intervention with families to reduce relapse.

1 reference

12 December 2020

Community management of schizophrenia. A two-year follow-up of a behavioural intervention with families.

1 reference

12 December 2020

Inpatient family intervention: a randomized clinical trial. II. Results at hospital discharge

1 reference

12 December 2020

Continuous versus targeted medication in schizophrenic outpatients: outcome results

1 reference

12 December 2020

Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication

1 reference

12 December 2020

Family management in the prevention of exacerbations of schizophrenia: a controlled study.

1 reference

12 December 2020

A trial of family therapy versus a relatives' group for schizophrenia. Two-year follow-up

1 reference

12 December 2020

Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome

1 reference

12 December 2020

Family management of schizophrenia: a comparison of behavioral and supportive family treatment

1 reference

12 December 2020

Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year

1 reference

12 December 2020

The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients

1 reference

12 December 2020

Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia

1 reference

12 December 2020

Intermittent vs maintenance medication in schizophrenia. Two-year results

1 reference

12 December 2020

A randomized clinical trial of inpatient family intervention. IV. Followup results for subjects with schizophrenia.

1 reference

12 December 2020

Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates

1 reference

12 December 2020

Depot neuroleptics: a comparative review of standard, intermediate, and low-dose regimens.

1 reference

12 December 2020

Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02238750

1 reference

release_inwt6atvkfgctoqqfzczxgbsma

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/inwt6atvkfgctoqqfzczxgbsma

24 November 2022

mapped directly with Wikidata item

1 reference